| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7339501040a829287a6ee236092a9e00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d7432f90455736f18a1c3e0bb77a7c07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca7c109e96ea002b896c90befc5cf334 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3839
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3847 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02 |
| filingDate |
2010-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9869e295c9ed9659a7027371193f3d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f31a29290a5dd780d1ef3e8e00ccc57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e65d9a09c61bbfef6d37e0808ae62b05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b861c05e2477ac732bf2574c86c36b74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6d119a9f315498785e2327f3e208978 |
| publicationDate |
2016-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
PL-223475-B1 |
| titleOfInvention |
Method of obtaining tissue engineered product for reconstruction and regeneration of bone tissue and tissue engineered product |
| abstract |
The subject matter of invention is a method for obtaining a tissue engineered product for the reconstruction and regeneration of bone tissue, the tissue engineered product, and its applications. In more detail: the invention represents the method for obtaining the tissue engineered product in cell culture conditions in vitro on degradable material. The product consists almost entirely of natural components, which are produced by cells seeded on a resorbable material. When the cells come from the donor who is also the recipient of the graft, the product is composed of his/her own biological material. Such composition ensures immunological compatibility, which does not occur in the case of biological material obtained from an incompatible donor or when the biological material is of animal origin, which is often the case in current clinical practice. |
| priorityDate |
2010-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |